Mid America Pet Food, LLC
Letter data
- Company
- Mid America Pet Food, LLC
- Recipient
- Jeff Caswell | Chief Executive Officer | Mid America Pet Food, LLC | 2024 N. Frontage Road | Mount Pleasant | , | TX | 75455-6474 | United States | mfrederking@MAPF.com
- Issue date
- 2025-08-21
- Posted date
- Not available
- FDA office
- Center for Veterinary Medicine
- Subject
- Not available
- Product
- Animal & Veterinary | Food & Beverages
- CMS ID
- 681516
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Mid America Pet Food, LLC
MARCS-CMS 681516 —
August 21, 2025
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA EMAIL WITH READ RECEIPT: NO HARD COPY TO FOLLOW
Product:
Animal & Veterinary
Food & Beverages
Recipient:
Recipient Name
Jeff Caswell
Recipient Title
Chief Executive Officer
Mid America Pet Food, LLC
2024 N. Frontage Road
Mount Pleasant
,
TX
75455-6474
United States
mfrederking@MAPF.com
Issuing Office:
Center for Veterinary Medicine
United States
Secondary Issuing Offices
United States
Dear Jeff Caswell,
The United States Food and Drug Administration has completed evaluation of your facility’s corrective actions in response to our Warning Letter CMS 681516, dated November 22, 2024. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your facility from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your facility to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Andrew Howard
For
Kelli Wilkinson
Branch Director, Office of Surveillance and Compliance
Center for Veterinary Medicine
U.S. Food and Drug Administration
Content current as of:
08/28/2025
Regulated Product(s)
Animal & Veterinary
Food & Beverages